Internal Medicine, Endocrinology, Diabetes, & Metabolism · Port Orange, FL
NPI
1912229121
Since 2010
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
740 Dunlawton Ave
Port Orange, FL, 32127
Phone (386) 763-1000
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$1.1M
3,855 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Silvia M Cuadra Mongalo prescribed most often to Medicare patients was Farxiga (Dapagliflozin Propanediol), with 543 prescriptions and refills. In total Silvia M Cuadra Mongalo wrote 3,855 Medicare prescriptions that cost $1.1M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-03-19.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Farxiga Dapagliflozin Propanediol | 543 | 641 | 89 | $245K |
| Rosuvastatin Calcium Generic | 254 | 695 | 83 | $11K |
| Levothyroxine Sodium Generic | 250 | 661 | 65 | $4,231 |
| Pioglitazone Hcl Generic | 186 | 461 | 54 | $7,367 |
| Bydureon Bcise Exenatide Microspheres | 162 | 202 | 41 | $113K |
| Novolin N Flexpen Insulin Nph Human Isophane | 159 | 239 | 35 | $4,319 |
| Metformin Hcl Generic | 157 | 453 | 50 | $3,840 |
| Ultra Thin Pen Needle, Diabetic | 156 | 358 | 61 | $2,648 |
| Glimepiride Generic | 146 | 352 | 47 | $2,952 |
| Insulin Glargine-Yfgn Generic | 121 | 152 | 24 | $12K |
| Qtern Dapagliflozin/Saxagliptin Hcl | 117 | 145 | 16 | $54K |
| Ozempic Semaglutide | 113 | 121 | 19 | $106K |
| Metformin Hcl Er Metformin Hcl | 99 | 293 | 40 | $2,225 |
| Novolog Flexpen Insulin Aspart | 93 | 116 | 24 | $10K |
| Atorvastatin Calcium Generic | 84 | 229 | 27 | $2,845 |
Brand drugs: 1,939 claims; generic drugs: 1,592 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Silvia M Cuadra Mongalo were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.